COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,158 Articles (22,703 medRxiv, 8,455 bioRxiv)

Most recent first Previous |  Page 1694: Articles 16931-16940  | Next

A novel SARS-CoV-2 related virus with complex recombination isolated from bats in Yunnan province, China
Li, L., Wang, J., Ma, X., Li, J., Yang, X., Shi, W., Duan, Z.
10.1101/2021.03.17.435823 — Posted: 2021-03-18
Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies
Greaney, A. J., Starr, T. N., Barnes, C. O., Weisblum, Y., Schmidt, F., Caskey, M., Gaebler, C., Agudelo, M., Finkin, S., Wang, Z., Poston, D., Muecksch, F., Hatziioannou, T., Bieniasz, P. D., Robbiani, D. F., Nussenzweig, M. C., Bjorkman, P. J., Bloom, J. D.
10.1101/2021.03.17.435863 — Posted: 2021-03-18
Myocarditis in naturally infected pets with the British variant of COVID-19
Ferasin, L., Fritz, M., Ferasin, H., Becquart, P., Legros, V., Leroy, E. M.
10.1101/2021.03.18.435945 — Posted: 2021-03-18 Discussion: Onsite
A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses
Tauzin, A., Nayrac, M., Benlarbi, M., Gong, S. Y., Gasser, R., Beaudoin-Bussieres, G., Brassard, N., Laumaea, A., Vezina, D., Prevost, J., Anand, S. P., Bourassa, C., Gendron-Lepage, G., Medjahed, H., Goyette, G., Niessl, J., Tastet, O., Gokool, L., Morrisseau, C., Arlotto, P., Stamatatos, L., McGuire, A. T., Larochelle, C., Uchil, P., Lu, M., Mothes, W., De Serres, G., Moreira, S., Roger, M., Richard, J., Martel-Laferriere, V., Duerr, R., Tremblay, C., Kaufmann, D. E., Finzi, A.
10.1101/2021.03.18.435972 — Posted: 2021-03-18
U.S. adolescents' mental health and COVID-19-related changes in technology use, Fall 2020
Burke, T. A., Kutok, E. R., Dunsinger, S., Nugent, N. R., Patena, J. V., Riese, A., Ranney, M. L.
10.1101/2021.03.15.21253598 — Posted: 2021-03-17
Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines
Monin-Aldama, L., Laing, A. G., Munoz-Ruiz, M., McKenzie, D. R., del Molino del Barrio, I., Alaguthurai, T., Domingo Vila, C., Hayday, T. S., Graham, C., Seow, J., Abdul-Jawad, S., Kamdar, S., Harvey-Jones, E., Graham, R., Cooper, J., Khan, M., Vidler, J., Kakkassery, H., Sinha, S., Davis, R., Dupont, L., Francos Quijorna, I., Lee, P., Eum, J., Conde Poole, M., Joseph, M., Davies, D., Wu, Y., Montes, A., Harries, M., Rigg, A., Spicer, J., Malim, M. H., Fields, P., Patten, P., Di Rosa, F., Papa, S., Tree, T., Doores, K., Hayday, A. C., Irshad, S.
10.1101/2021.03.17.21253131 — Posted: 2021-03-17 Discussion: Onsite
Characteristics and risk factors for SARS-CoV-2 among children in Italy: a cross-sectional study in 20 pediatric centers
Lazzerini, M., Sforzi, I., Trapani, S., Biban, P., Salvigni, D., Mariani, I., Villa, G., Tibaldi, J., Bertacca, L., Felici, E., Perricone, G., Parrino, R., Gioe', C., Lega, S., Conte, M., Marchetti, F., Magista, A., Berlese, P., Martelossi, S., Vaienti, F., Valletta, E., Mauro, M., Dall Amico, R., Fasoli, S., Gatto, A., Chiaretti, A., Dragovic, D., Pascolo, P., Pilotto, C., Liguoro, I., Miorin, E., Saretta, F., Trobia, G., Di Stefano, A., Orlandi, A., Cardinale, F., Lubrano, R., Testa, A., Binotti, M., Moressa, V., Barbi, E., Armocida, B.
10.1101/2021.03.17.21253610 — Posted: 2021-03-17
The impact of policy timing on the spread of COVID-19
Elitzur, M., Kaplan, S., Ivezic, Z., Zilberman, D.
10.1101/2021.03.16.21253764 — Posted: 2021-03-17 Discussion: Onsite
The Influence of Covid-19 Vaccine on Daily Cases, Hospitalization, and Death Rate in Tennessee: A Case Study in the United States
Roghani, A.
10.1101/2021.03.16.21253767 — Posted: 2021-03-17
Structural basis of anti-SARS-CoV-2 activity of hydroxychloroquine: specific binding to NTD/CTD and disruption of LLPS of N protein
Dang, M., Song, J.
10.1101/2021.03.16.435741 — Posted: 2021-03-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).